Picture [LSE] – The Business Web Portal 650x65px
Organisation › Details

Evotec SE (FSE: EVT, MDA X/TecDAX)

Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. We operate worldwide providing the highest quality stand-alone and integrated drug discovery solutions, covering all activities from target-to-clinic to meet the industry's need for innovation and efficiency in drug discovery (EVT Execute). The Company has established a unique position by assembling top-class scientific experts and integrating state-of-the-art technologies as well as substantial experience and expertise in key therapeutic areas including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology and infectious diseases. On this basis, Evotec has built a broad and deep pipeline of more than 80 partnered product opportunities at clinical, pre-clinical and discovery stages (EVT Innovate). Evotec has established multiple long-term discovery alliances with partners including Bayer, CHDI, Sanofi or UCB and development partnerships with e.g. with Sanofi in the field of diabetes, with Pfizer in the field of tissue fibrosis and Celgene in the field of neurodegenerative diseases. *


Period Start 2019-04-01 restructured
  Group Evotec (Group)
  Predecessor Evotec AG (FSE: EVT, TecDAX)
Products Industry drug discovery technology
  Industry 2 drug discovery services
Region Region Hamburg
  Country Germany
  Street 7 Essener Bogen
  City 22419 Hamburg
    Address record changed: 2020-01-01
Basic data Employees F: 1,001 to 5,000 (2018-12-31)
  Currency EUR
  Annual sales 375,405,000 (revenues, consolidated (2018) 2018-12-31)
  Profit 84,056,000 (2018-12-31)
  Cash 109,055,000 (2018-12-31)
    * Document for �About Section�: Evotec AG. (5/31/18). "Press Release: Evotec Forms Academic Bridge »LAB591« with Arix Bioscience and Fred Hutchinson Cancer Research Center". Hamburg.
Record changed: 2020-01-09


Picture [LSUS] – The Business Web Portal 650x65px

More documents for Evotec (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture [LSA] – The Business Web Portal 650x89px

» top